Caprock Group, LLC

Position in HLN — Haleon plc

CIK 1610769 BOISE, ID

Position in HLN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$449,146

-$83,610 QoQ

Shares Held

48,140

-8.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#205

of 639 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Caprock Group, LLC holds $122,719,355 across 16 Drug Manufacturers - Specialty & Generic names. HLN ranks #9 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	1,409,759	$112,400,085
2	TEVA	Teva Pharmaceutical Industries Ltd	77,986	$2,642,165
3	ELAN	Elanco Animal Health Inc	55,602	$1,368,365
4	VTRS	Viatris Inc	75,955	$1,206,165
5	ZTS	Zoetis Inc.	13,819	$993,033
6	TAK	Takeda Pharmaceutical Co Ltd	40,725	$652,821
7	NBIX	Neurocrine Biosciences Inc	3,295	$555,339
8	RDY	Dr Reddys Laboratories Ltd	32,404	$469,533

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$449,146	48,140	-8.6%	Shares	Sole	2026-07-27
2025-12-31	$532,756	52,696	+1.0%	Shares	Sole	2026-01-28
2025-09-30	$468,063	52,181	+16.2%	Shares	Sole	2025-11-06
2025-03-31	$461,928	44,891	+3.0%	Shares	Sole	2025-05-15
2024-12-31	$415,619	43,566	+13.8%	Shares	Sole	2025-01-23
2024-09-30	$404,864	38,267	-28.4%	Shares	Sole	2024-11-07
2024-06-30	$441,166	53,410	+21.9%	Shares	Sole	2024-08-06
2024-03-31	$372,099	43,828	+29.1%	Shares	Sole	2024-04-29
2023-12-31	$279,482	33,959	+19.5%	Shares	Sole	2024-01-18
2023-09-30	$236,771	28,424	+47.4%	Shares	Sole	2023-10-18
2023-06-30	$161,566	19,280	+5.0%	Shares	Sole	2023-08-10
2023-03-31	$149,507	18,367	+59.4%	Shares	Sole	2023-04-26
2022-12-31	$92,176	11,522	—	Shares	Sole	2023-01-23
No filing history on record for this holder in this stock.